Meta-analysis and the meta-epidemiology of clinical research

BMJ

Volumn 316, Issue 7127, 1998, Pages 311-

  Julian, Desmond ^a   Lorier, Jacques le ^b   Grégoire, Geneviève ^b  

^a Cardio Vascular Clin Trials Forum   (United Kingdom)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EPIDEMIOLOGY; META ANALYSIS; NOTE;

CLINICAL TRIALS; EPIDEMIOLOGIC RESEARCH DESIGN; META-ANALYSIS;

EID: 85007719446     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7127.311b     Document Type: Letter

References (7)

1. Naylor CD. BMJ 1997; 315: 617–9. (13 September.)
2. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects BMJ 1997; 315: 640–5. (13 September.)
3. Naylor CD. BMJ 1997; 315: 617–9. (13 September.)
4. Le Lorier J, Grégoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized controlled trials. N Engl J Med 1997; 337: 537–542.
5. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349–360.
6. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685.
7. FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322.